Nicardipine in the treatment of raynaud'
β
Fredrick M. Wigley; Robert A. Wise; Raymond Malamet; Thomas E. Scott
π
Article
π
1987
π
John Wiley and Sons
π
English
β 635 KB
A new calcium channel blocker, nicardipine, was studied for treatment of Raynaud's phenomenon in a double-blind, placebo-controlled, crossover trial during the winter months. Clinical response was assessed by a patient-kept diary of symptoms and finger systolic pressure that was measured at room tem